NewslettersMammary Cell NewsOrganoid NewsS6K1 Amplification Confers Innate Resistance to CDK4/6 Inhibitors through Activating C-myc Pathway in Patients with Estrogen Receptor-Positive Breast CancerBy lbeveridge - September 1, 20220182Investigators elucidated the molecular hallmarks and therapeutically actionable features of patients with resistance to CDK4/6 inhibitors.[Molecular Cancer]Abstract